Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder
Benjamin Enns, Emanuel Krebs, David G. T. Whitehurst, Didier Jutras‐Aswad, Bernard Le Foll, M. Eugenia Socías, Bohdan Nosyk
Topics & Concepts
Opioid use disorderMethadoneBuprenorphineMedicine(+)-NaloxoneQuality-adjusted life yearCost effectivenessPsychiatryOpioidInternal medicineReceptorRisk analysis (engineering)Opioid Use Disorder TreatmentPain Management and Opioid UseSubstance Abuse Treatment and Outcomes